Outcome of Severe Pneumonia in Pediatric Patients Aged 2 Months to 5 Years

Authors

  • Uzma Yasmeen Department of Paediatrics Allied Hospital-1 Faisalabad, Punjab, Pakistan
  • Samra Liaqat Department of Paediatrics Allied Hospital-1 Faisalabad, Punjab, Pakistan
  • Aamer Naseer Qureshi Department of Paediatrics Allied Hospital-1 Faisalabad, Punjab, Pakistan
  • M. Irfan Farooqi Department of Paediatrics Allied Hospital-1 Faisalabad, Punjab, Pakistan
  • Sadia Zafar Department of Paediatrics Allied Hospital-1 Faisalabad, Punjab, Pakistan
  • Fauzia Aamer Department of Hematology, Services Institute of Medical Sciences Lahore, Punjab, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i7.3097

Keywords:

Pneumonia, hospital stay, vaccination, ventilation, mortality

Abstract

Objective: To determine the frequency of outcome of severe pneumonia in children having age from 2 months to 5 years. Study Type: Descriptive Cross sectional study. Setting: Department of Pediatrics, Allied Hospital, Faisalabad. Duration: 14 March 2025 - 14 June 2025. Methodology: Total 190 patients with severe pneumonia of age 2 months to 5 years were included. Children with congenital lung pathologies like cystic fibrosis, immunodeficiency, recurrent chest infections in cerebral palsy patients, penetrating lung injuries with pneumonia, congenital heart disease, reactive airway disease, asthma, and bronchiolitis, as well as malnutrition were excluded. All patients received the WHO's recommended treatment regimen for treating pneumonia. IV antibiotics i.e cefzone and penicillin were injected after proper dose calculation. Patient’s oxygen saturation and respiratory rate were monitored hourly by a staff nurse.  Report of arterial blood sample sent to the laboratory as well as adverse outcomes including prolonged hospital stay, need for mechanical ventilation and moratlity were recorded. Results: The mean age was 3.82+1.17 years.  According to the gender distribution, 98 cases (51.58%) were male and 92 cases (48.42%) were female. According to descriptive duration of illness, 124 (65.26%) were ≤3 days and 66 (34.74%) were >3 days. Mean duration of illness was 4.24 ± 2.87 days.  According to vaccination status descriptive statistics, there were 86 unvaccinated cases (45.26%) and 104 vaccinated cases (54.74%). The mean hospital stay was 10.04 + 6.26 days. Prolonged hospital stay, need for mechanical ventilation and mortality were noted in 77.53%, 33.18% and 9.47% respectively. Conclusion: Pneumonia specially under five years of age is a major cause of morbidity and mortality.

Downloads

Download data is not yet available.

References

1. Dinku H, Amare D, Mulatu S, Abate MD. Predictors of prolonged hospitalization among children aged 2-59 months with severe community acquired pneumonia in public hospitals of Benishangul-Gumuz Region, Ethiopia: a multicenter retrospective follow-up study. Front Pediatr. 2023;11:1189155.

https://doi.org/10.3389/fped.2023.1189155

2. Barday MM, Slogrove AL, Engelbrecht AL. Risk factors associated with the severity of pneumonia in a cohort of hospitalized children in a rural setting. J Pan Afr Thorac Soc. 2022;3(3):130-9.

https://doi.org/10.25259/jpats_26_2022

3. Tegenu K, Geleto G, Tilahun D, Bayana E, Bereke B. Severe pneumonia: treatment outcome and its determinant factors among under-five patients, Jimma, Ethiopia. SAGE Open Med. 2022;10:1-7.

https://doi.org/10.1177/20503121221078445

4. Iqbal N, Zafar F, Iqbal M. Factors influencing the outcome of severe pneumonia among children having age from 2 months to 5 years in a tertiary healthcare hospital. Pak J Health Sci. 2013;14(1):60-5.

https://doi.org/10.54393/pjhs.v4i01.480

5. Le Roux DM, Nicol MP, Vanker A, Nduru PM, Zar HJ. Fcators associated with serious outcomes of pneumonia among children in a birth cohort in South Africa. PLoS One. 2021;16(8):e0255790.

https://doi.org/10.1371/journal.pone.0255790

6. Mathew JL, Singhi S, Ray P, Hagel E, Saghafian Hedengren S, Bansal A, et al. Etiology of community acquired pneumonia among children in India: Prospective, cohort study. J Glob Health 2015;5:1 9.

https://doi.org/10.7189/jogh.05.020418

7. Champatiray J, Satapathy J, Kashyap B, Mondal D. Clinico-aetiological study of severe and very severe pneumonia in two months to five years children in a tertiary health care centre in Odisha, India. J Clin Diagn Res. 2017;11:SC06 10.

https://doi.org/10.7860/jcdr/2017/26027.10595

8. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835 45.

https://doi.org/10.1056/nejmoa1405870

9. Yudhavir S, Pramod S, Singh A, Payal V. Bacteriological and Clinical Profile of Community Acquired Pneumonia in hospitalised children with associated co-morbidity in a tertiary care centre of Western Rajasthan, India. Int J Contemp Paediatr 2016;5:2320 7.

https://doi.org/10.18203/2349-3291.ijcp20163682

10. Huang CY, Chang L, Liu CC, Huang YC, Chang LY, Huang YC, et al., Risk factors of progressive community acquired pneumonia in hospitalized children: A prospective study. J Microbiol Immunol Infection. 2015 Feb 1;48(1):36–42.

https://doi.org/10.1016/j.jmii.2013.06.009

11. Kumar M, Badakali A, Mirji G, Vanaki RN, Pol R. Clinical profile and outcome of acute lower respiratory tract infection in children aged between 2 months to 5 years. Int J Contemp Pediatr. 2016;4:105 11.

https://doi.org/10.18203/2349-3291.ijcp20164587

12. Tiewsoh K, Lodha R, Pandey RM, Broor S, Kalaivani M, Kabra SK. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr 2009;9:15.

https://doi.org/10.1186/1471-2431-9-15

13. Jroundi I, Mahraoui C, Benmessaoud R, Moraleda C, Tligui H, Seffar M, et al. Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco. Int J Infect Dis. 2014;28:164–70.

https://doi.org/10.1016/j.ijid.2014.07.027

14. Dembele BPP, Kamigaki T, Dapat C, Tamaki R, Saito M, Saito M, et al. Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study. BMJ Open. 2019;9(3):e026895.

https://doi.org/10.1136/bmjopen-2018-026895

15. Tsegaw H, Yimam M, Nureye D, Woldeselassie W, Hambisa S. Predictors of treatment outcomes among pediatric patients hospitalized with pneumonia in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Adv Pharmacol Pharm Sci. 2021;2021:1–7.

https://doi.org/10.1155/2021/6690622

16. Gutu B, Yoseph L, Balisa M. Clinical treatment outcomes of pneumonia among hospitalized pediatric patients in Nekemte Referral Hospital, Pediatrics Ward, Ethiopia. World J Pharm Pharm Sci. 2017;6(02):68–84.

17. Zhu Z, Zhang T, Guo W, Ling Y, Tian J, Xu Y. Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis. 2021;21:1–8.

https://doi.org/10.1186/s12879-021-05830-4

18. Theodoratou E, Al-Jilaihawi S, Woodward F, Ferguson J, Jhass A, Balliet M, et al. The effect of case management on childhood pneumonia mortality in developing countries. Int J Epidemiol. 2010;39(Suppl 1):i155–71.

https://doi.org/10.1093/ije/dyq032

19. Tiewsoh K, Lodha R, Pandey RM, Broor S, Kalaivani M, Kabra SK. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr. 2009;9:15.

https://doi.org/10.1186/1471-2431-9-15

20. Salih KMA, AliBilal J, Karsani AH. Risk factors of mortality among children admitted with severe pneumonia at a reference hospital in Khartoum, Sudan. Am J Med Med Sci. 2015;5(3):130–4.

https://doi.org/10.7860/jcdr/2015/13771.6377

21. Shi T, Chen C, Huang L. Risk factors for mortality from severe community-acquired pneumonia in hospitalized children transferred to the pediatric intensive care unit. Pediatr Neonatol. 2020;61:(6)577–83.

https://doi.org/10.1016/j.pedneo.2020.06.005

22. Ao XX. The epidemiology of hospital death following pediatric severe community-acquired pneumonia. Ital J Pediatr. 2021;47:(1)25.

https://doi.org/10.1186/s13052-021-00966-0

23. Meliyanti A, Rusmawatiningtyas D, Makrufardi F, Arguni E. Factors associated with mortality in pediatric pneumonia patients supported with mechanical ventilation in developing country. Heliyon. 2021;7:(5)e07063.

https://doi.org/10.1016/j.heliyon.2021.e07063

24. Ferdous F, Ahmed S, Das SK, Chisti MJ, Nasrin D, Kotloff KL, et al. Pneumonia mortality and healthcare utilization in young children in rural Bangladesh: a prospective verbal autopsy study. Trop Med Health. 2018;46:17.

https://doi.org/10.1186/s41182-018-0099-4

25. Tegenu K, Geleto G, Tilahun D, Bayana E, Bereke B. Severe pneumonia: treatment outcome and its determinant factors among under-five patients, Jimma, Ethiopia. SAGE Open Med. 2022;10:20503121221078445.

https://doi.org/10.1177/20503121221078445

26. Dheresa M, Dessie Y, Negash B, Balis B, Getachew T, Mamo Ayana G, et al. Child vaccination coverage, trends and predictors in Eastern Ethiopia: implication for sustainable development goals. J Multidiscip Healthc. 2021;14:2657–67.

https://doi.org/10.2147/jmdh.s325705

Downloads

Published

2025-07-20

How to Cite

Yasmeen, U., Liaqat, S., Qureshi, A. N., Farooqi, M. I., Zafar, S., & Aamer, F. (2025). Outcome of Severe Pneumonia in Pediatric Patients Aged 2 Months to 5 Years. Indus Journal of Bioscience Research, 3(7), 1770-1774. https://doi.org/10.70749/ijbr.v3i7.3097